种族、族裔、F8基因变异与抑制物风险:My Life Our Future血友病A数据库分析
基于My Life Our Future数据库中超过6000例轻、中、重度血友病A参与者的人口学、临床及F8序列数据,采用校正逻辑回归分析。黑人和西班牙裔重度血友病A受试者的抑制物风险高于非西班牙裔白人(校正比值比分别为1.65和1.88),但F8基因非同义单核苷酸多态性与抑制物发生无关;内含子22倒位与其他大型F8结构改变的抑制物风险无差异。
要点
- 黑人和西班牙裔重度血友病A患者的抑制物风险高于非西班牙裔白人。
- F8基因非同义单核苷酸多态性与抑制物发生无关。
- 内含子22倒位与其他大型F8结构改变的抑制物风险无差异。
核心结论
- F8基因非致病性非同义单核苷酸多态性与抑制物风险无关。
- 内含子22倒位突变相关的抑制物风险与其他阻止完整FVIII表达的大型F8结构改变相似。
研究设计与样本
- 对My Life Our Future数据库中超过6000例轻、中、重度血友病A参与者的入口学、临床及F8序列数据进行校正逻辑回归分析。
主要发现
- 黑人和西班牙裔重度血友病A受试者的抑制物风险高于非西班牙裔白人,校正比值比分别为1.65(95% CI: 1.22-2.21)和1.88(95% CI: 1.43-2.48)。
- F8基因非同义单核苷酸多态性与抑制物发生无关。
- 重度血友病A受试者中,内含子22倒位与其他大型F8结构改变的抑制物风险无差异。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Several studies have suggested Black and Hispanic hemophilia A (HA) patients in the United States suffer higher incidences of neutralizing anti-FVIII antibodies (inhibitors) than their White counterparts. The possible influence of nonsynonymous single-nucleotide polymorphisms (ns-SNPs) in the F8 gene sequence has been proposed as a possible race-associated contributing factor. Some earlier studies indicated that intron-22 inversion mutations carry a lower inhibitor risk than other mutations resulting in large F8 gene disruptions. OBJECTIVES: The objectives of the study were to test the following hypotheses: (1) The risk of developing an inhibitor differs among racial/ethnic groups in the United States, (2) specific non-HA-causing ns-SNPs in the F8 gene are correlated with inhibitor risk, and (3) inhibitor risk associated with intron-22 inversions mutations is similar to that associated with other large structural changes in the F8 gene. METHODS: Adjusted logistic regression analysis of the "My Life Our Future" database containing demographic, clinical, and F8 sequence data from >6000 mild, moderate, and severe HA participants. RESULTS: Black and Hispanic severe HA subjects had a higher inhibitor risk than non-Hispanic Whites (adjusted odds ratio = 1.65, 95% CI: 1.22-2.21 and adjusted odds ratio = 1.88, 95% CI: 1.43-2.48), confirming this racial/ethnic/medical disparity; however, F8 ns-SNPs were not associated with inhibitor development. There was no difference in inhibitor risk among severe HA subjects with an intron-22 inversion vs other large structural changes in the F8 gene. CONCLUSIONS: Nonpathogenic ns-SNPs in the F8 gene are not correlated with inhibitor risk. Inhibitor risk associated with intron-22 inversion mutations is similar to that of other large structural changes in F8 that preclude intact FVIII expression.
引用
- Ahmed AE, Pratt KP. Race, ethnicity, F8 variants, and inhibitor risk: analysis of the "My Life Our Future" hemophilia A database. J Thromb Haemost. 2022. PMID: 36696179. doi:10.1016/j.jtha.2022.12.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。